| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9149(87)90160-3 |
| P698 | PubMed publication ID | 2884855 |
| P2093 | author name string | H P Madsbu | |
| D Torvik | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 68G-72G | |
| P577 | publication date | 1987-05-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension. | |
| P478 | volume | 59 |
| Q36495545 | Alpha 1 blockers. Safe, effective treatment for hypertension |
| Q38365267 | Alpha-1 blockers. A new generation of antihypertensive agents |
| Q37608000 | Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism |
| Q34183262 | Cost-effective therapy for hypertension |
| Q37099019 | Doxazosin in the current treatment of hypertension |
| Q67897246 | Doxazosin in the treatment of mild or moderate essential hypertension: An echocardiographic study |
| Q44621490 | Doxazosin, an alpha-1 antagonist, prevents further progression of the advanced atherosclerotic lesion in hypercholesterolemic hamsters |
| Q39469038 | Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension |
| Q31145309 | Effects of doxazosin on serum lipids: A review of the clinical data and molecular basis for altered lipid metabolism |
| Q42620274 | Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol |
| Q73503928 | Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertension |
| Q40398442 | Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents |
Search more.